Tower Research Capital (TRC)’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

Tower Research Capital (TRC)’s Portfolio FWP Stock Details FWP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-43	Closed	-$6K	–	4336
2017 Q2	$6K	Hold	43	–	–	﹤0.01%	1943
2017 Q1	$6K	Buy	+43	New	+$8.1K	﹤0.01%	2146
2016 Q2	–	Sell	-42	Closed	-$5K	–	5287
2016 Q1	$5K	Buy	+42	New	+$4.71K	﹤0.01%	2792
2015 Q4	–	Sell	-53	Closed	-$9K	–	5361
2015 Q3	$9K	Buy	53 +16	+43%	+$3.36K	﹤0.01%	2419
2015 Q2	$10K	Sell	37 -12	-24%	-$2.87K	﹤0.01%	2740
2015 Q1	$10K	Buy	49 +2	+4%	+$324	﹤0.01%	2824
2014 Q4	$7K	Buy	+47	New	+$6.78K	﹤0.01%	2500

Other funds holding FWP

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s FWP Position: Q3 2017 in Review

Tower Research Capital (TRC) sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q3 2017, closing a stake of 43 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in FWP in Q4 2014 and held it in 7 quarters. The position peaked at $10K in Q2 2015. 19 funds tracked by Wall St. Rank hold FWP as of Q3 2017.

Tower Research Capital (TRC) reported no remaining Forward Pharma A/S American Depositary Shares position as of Q3 2017 after selling out during the quarter.
Tower Research Capital (TRC) sold 43 Forward Pharma A/S American Depositary Shares shares in Q3 2017, an estimated $6K.
Tower Research Capital (TRC) first reported a position in Forward Pharma A/S American Depositary Shares in Q4 2014 and held it in 7 quarters.
Tower Research Capital (TRC)'s Forward Pharma A/S American Depositary Shares position peaked at $10K in Q2 2015.
19 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q3 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.